Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.62% |
| 2 | Technology | 7.54% |
| 3 | Financials | 6.93% |
| 4 | Consumer Discretionary | 6.74% |
| 5 | Industrials | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TOIIW
3651
CALL
The Oncology Institute Warrant
TOIIW
$4.35M
| $276K | ﹤0.01% |
+27,450
| New | +$39.4K |
|
|
MARK
3652
DELISTED
Remark Holdings, Inc.
MARK
| $276K | ﹤0.01% |
+11,703
| New | +$180K |
|
3653
CALL
Insmed
INSM
$22.4B
| $275K | ﹤0.01% |
10,000
| – | – |
|
3654
United Natural Foods
UNFI
$3.04B
| $275K | ﹤0.01% |
15,113
-697,988
| -98% | -$10.5M |
|
3655
International Money Express
IMXI
$389M
| $274K | ﹤0.01% |
+21,955
| New | +$223K |
|
|
FLNT
3656
Fluent
FLNT
$106M
| $273K | ﹤0.01% |
25,536
-3,219
| -11% | -$36K |
|
3657
iBio
IBIO
$67.6M
| $273K | ﹤0.01% |
246
+72
| +41% | +$47.1K |
|
3658
Lifecore Biomedical
LFCR
$162M
| $273K | ﹤0.01% |
34,303
-60,417
| -64% | -$623K |
|
|
CLSD
3659
DELISTED
Clearside Biomedical
CLSD
| $272K | ﹤0.01% |
9,642
+4,896
| +103% | +$144K |
|
3660
Protara Therapeutics
TARA
$214M
| $271K | ﹤0.01% |
9,230
-33,189
| -78% | -$1.03M |
|
|
AXLA
3661
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $271K | ﹤0.01% |
+1,960
| New | +$240K |
|
3662
Harmonic Inc
HLIT
$1.15B
| $270K | ﹤0.01% |
56,778
-6,598
| -10% | -$36.9K |
|
3663
CALL
Southern Company
SO
$108B
| $270K | ﹤0.01% |
+5,200
| New | +$289K |
|
|
3664
PUT
Southern Company
SO
$108B
| $270K | ﹤0.01% |
+5,200
| New | +$289K |
|
|
SDC
3665
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $270K | ﹤0.01% |
34,179
-774,381
| -96% | -$5.25M |
|
3666
Grid Dynamics Holdings
GDYN
$569M
| $269K | ﹤0.01% |
38,961
-126,938
| -77% | -$1.04M |
|
|
PVLA
3667
Palvella Therapeutics
PVLA
$2.05B
| $269K | ﹤0.01% |
+1,086
| New | +$254K |
|
3668
Citizens Community Bancorp
CZWI
$212M
| $268K | ﹤0.01% |
38,997
-3,755
| -9% | -$26.3K |
|
3669
Duluth Holdings
DLTH
$152M
| $268K | ﹤0.01% |
36,424
-238,302
| -87% | -$1.22M |
|
3670
Erie Indemnity
ERIE
$13B
| $268K | ﹤0.01% |
1,394
-61,026
| -98% | -$10.7M |
|
3671
Pangaea Logistics
PANL
$484M
| $266K | ﹤0.01% |
105,954
+87,450
| +473% | +$190K |
|
|
PHX
3672
DELISTED
PHX Minerals
PHX
| $266K | ﹤0.01% |
99,342
+78,642
| +380% | +$294K |
|
|
ALYA
3673
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
| $266K | ﹤0.01% |
153,502
-1,188
| -0.8% | -$2.08K |
|
|
HNP
3674
DELISTED
Huaneng Power Intl, Inc.
HNP
| $266K | ﹤0.01% |
17,633
-3,558
| -17% | -$52.1K |
|
|
ODT
3675
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $265K | ﹤0.01% |
+6,260
| New | +$203K |
|
Similar funds
Millennium Management's Q2 2020 Portfolio in Review
As of Q2 2020, Millennium Management held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 8.6% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Millennium Management's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Millennium Management added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Millennium Management's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Millennium Management fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Millennium Management's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Millennium Management opened 1,140 new positions and closed 798 in Q2 2020.
- Millennium Management's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.